Abed Agbarya

BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors

Elizabeth Dudnik, Nir Peled, Hovav Nechushtan et al. · Journal of Thoracic Oncology · 2018 · 220 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors

Barliz Waissengrin, Abed Agbarya, Esraa Safadi et al. · The Lancet Oncology · 2021 · 190 citations · Full text

Veterinary Medicine, Immunology, Immunization +13

Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: A randomised phase II study

Gil Bar‐Sela, Mira Wollner, Liat Hammer et al. · European Journal of Cancer · 2012 · 70 citations

Medicine, Oncology, Pharmacology +9

Impact of acupuncture and integrative therapies on chemotherapy‐induced peripheral neuropathy: A multicentered, randomized controlled trial

Eran Ben‐Arye, David Hausner, Noah Samuels et al. · Cancer · 2022 · 46 citations

Medicine, Neurology, Oncology +15

Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs

Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran et al. · Cancers · 2021 · 42 citations · Full text

Veterinary Medicine, Immunology, Oncology +17